Simon Rule, Guillaume Cartron, Christopher Fegan, Franck Morschhauser, Lingling Han, et al.. Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton’s tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059).
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2020, 34 (5), pp.1458-1461.
⟨10.1038/s41375-019-0658-7⟩.
⟨hal-03383683⟩